Keyword: Ireland

Buckley is one of a clutch of leaders hired by the Irish tech-enabled clinical research startup around the time of its $25 million series C round.

The Anglo-Irish cancer biotech has appointed ex-Tesaro CFO Tim Pearson to lead the company from its new site in Boston.

Edwards Lifesciences and Johnson & Johnson Vision Care have made multimillion-euro investments to boost their manufacturing capacity in Ireland.

WuXi NextCODE acquired Genomics Medicine Ireland as part of a $400 million investment.

U.K.-based CRO Fusion Antibodies is partnering with Analytics Engines.

The FDA granted a de novo clearance to Atlantic Therapeutics’ electrical muscle stimulator for women, for treating stress urinary incontinence.

Sublimity Therapeutics hired Jesse Hall as chief medical officer, as it looks to move its lead candidate into a phase 2b ulcerative colitis study.

Neurent Medical raised nearly $11 million in a series A round to commercialize its in-office treatment for persistent runny nose linked to rhinitis.

Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM.

We look at a selection of biopharma stories from across Europe this week.